Home › Companies › Utah Medical Products, Inc. › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Utah Medical Products, Inc.’s Form 8-K, filed May 4, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 1, 2026: 3 items on Utah Medical Products, Inc.’s Form 8-K, filed May 4, 2026: 3 passed (calculated).
Notable dissent: 1 other board item (28.8% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore Utah Medical Products, Inc. in the interactive database Compare manager voting policies
These tallies are Utah Medical Products, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 4, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elected James H. Beeson as a director of the Company | 1,708,941 | -- | -- | 692,032 | 372,329 | 71% | Passed (calculated) | — |
| Ratified the selection of Haynie & Co. as the Company’s independent public accounting firm for the year ended December 31, 2026 | 2,753,278 | 16,273 | 3,751 | -- | -- | 99.4% | Passed (calculated) | — |
| Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion | 2,354,919 | 38,451 | 7,603 | -- | 372,329 | 98% | Passed (calculated) | — |
Source: Utah Medical Products, Inc., Form 8-K, filed with the SEC on May 4, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
155 asset managers disclosed a vote on at least one Utah Medical Products, Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Utah Medical Products, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 5 wordings of this item as funds reported it.
47.7% of fund votes cast · no official result
Description as filed by funds: To elect two directors to serve terms expiring at the 2029 Annual Meeting and until successors are elected and qualified: Ernst G. Hoyer
The 52 asset managers below reported 357,398 for, 391,566 withheld, 1 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Datum One Series Trust | 0 | 0 | 0 | 169,724 | Withhold |
| Vanguard | 153,867 | 0 | 1 | 73 | For |
| Fidelity | 0 | 0 | 0 | 107,545 | Withhold |
| BlackRock | 89,024 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 48,242 | Withhold |
| HOTCHKIS & WILEY FUNDS /DE/ | 21,800 | 0 | 0 | 0 | For |
| ADVISORS SERIES TRUST | 17,595 | 0 | 0 | 0 | For |
| Principal | 16,287 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 0 | 0 | 0 | 14,602 | Withhold |
| Charles Schwab | 0 | 0 | 0 | 10,532 | Withhold |
| WisdomTree | 0 | 0 | 0 | 9,439 | Withhold |
| Prudential/PGIM | 8,000 | 0 | 0 | 497 | Mixed |
| Equitable | 5,115 | 0 | 0 | 3,250 | Mixed |
| American Century | 7,263 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 0 | 0 | 0 | 7,100 | Withhold |
| Empower | 6,500 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 0 | 5,619 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 5,035 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 5,000 | 0 | 0 | 0 | For |
| EA Series Trust | 3,278 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 0 | 3,227 | Withhold |
| Invesco | 3,122 | 0 | 0 | 0 | For |
| Series Portfolios Trust | 0 | 0 | 0 | 3,100 | Withhold |
| Goldman Sachs | 2,715 | 0 | 0 | 0 | For |
| TETON WESTWOOD FUNDS | 2,000 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).
Combines 5 wordings of this item as funds reported it.
69% of fund votes cast · no official result
Description as filed by funds: To elect two directors to serve terms expiring at the 2029 Annual Meeting and until successors are elected and qualified: James H. Beeson
The 52 asset managers below reported 515,864 for, 233,100 withheld, 1 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Datum One Series Trust | 0 | 0 | 0 | 169,724 | Withhold |
| Vanguard | 153,940 | 0 | 1 | 0 | For |
| Fidelity | 107,545 | 0 | 0 | 0 | For |
| BlackRock | 89,024 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 48,242 | Withhold |
| HOTCHKIS & WILEY FUNDS /DE/ | 21,800 | 0 | 0 | 0 | For |
| ADVISORS SERIES TRUST | 17,595 | 0 | 0 | 0 | For |
| Principal | 16,287 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 14,602 | 0 | 0 | 0 | For |
| Charles Schwab | 10,532 | 0 | 0 | 0 | For |
| WisdomTree | 9,439 | 0 | 0 | 0 | For |
| Prudential/PGIM | 8,000 | 0 | 0 | 497 | Mixed |
| Equitable | 5,115 | 0 | 0 | 3,250 | Mixed |
| American Century | 7,263 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,100 | 0 | 0 | 0 | For |
| Empower | 6,500 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 0 | 5,619 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 5,035 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 5,000 | 0 | 0 | 0 | For |
| EA Series Trust | 3,278 | 0 | 0 | 0 | For |
| Northern Trust | 3,227 | 0 | 0 | 0 | For |
| Invesco | 3,122 | 0 | 0 | 0 | For |
| Series Portfolios Trust | 3,100 | 0 | 0 | 0 | For |
| Goldman Sachs | 2,715 | 0 | 0 | 0 | For |
| TETON WESTWOOD FUNDS | 2,000 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: To hold an advisory vote on the Company's executive compensation program.
Utah Medical Products, Inc.’s own tally for this item (“Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion:”): 2,354,919 for, 38,451 against, per its Form 8-K filed May 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 153,571 | 0 | 0 | 0 | For |
| Fidelity | 107,545 | 0 | 0 | 0 | For |
| BlackRock | 89,024 | 0 | 0 | 0 | For |
| Dimensional | 48,242 | 0 | 0 | 0 | For |
| HOTCHKIS & WILEY FUNDS /DE/ | 21,800 | 0 | 0 | 0 | For |
| ADVISORS SERIES TRUST | 17,595 | 0 | 0 | 0 | For |
| Principal | 16,287 | 0 | 0 | 0 | For |
| WisdomTree | 9,439 | 0 | 0 | 0 | For |
| Prudential/PGIM | 8,497 | 0 | 0 | 0 | For |
| Equitable | 8,365 | 0 | 0 | 0 | For |
| American Century | 7,263 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,100 | 0 | 0 | 0 | For |
| TIAA | 5,619 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 5,035 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 5,000 | 0 | 0 | 0 | For |
| EA Series Trust | 3,278 | 0 | 0 | 0 | For |
| Northern Trust | 3,227 | 0 | 0 | 0 | For |
| Invesco | 3,122 | 0 | 0 | 0 | For |
| Goldman Sachs | 2,715 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 2,481 | 0 | 0 | 0 | For |
| TETON WESTWOOD FUNDS | 2,000 | 0 | 0 | 0 | For |
| Lincoln Financial | 1,985 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 1,389 | 0 | 0 | 0 | For |
| Brighthouse | 1,293 | 0 | 0 | 0 | For |
| SA FUNDS INVESTMENT TRUST | 1,260 | 0 | 0 | 0 | For |
Fund voting reports, all 43 managers: 543,092 for. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Renaissance | 139,799 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 117,577 | 0 | 0 | 0 | For |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 83,461 | 0 | 0 | 0 | For |
| BlackRock | 67,300 | 0 | 0 | 0 | For |
| State Street | 53,311 | 45 | 0 | 0 | For |
| T. Rowe Price | 33,413 | 0 | 0 | 0 | For |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 29,463 | 0 | 0 | 0 | For |
| Cardinal Capital Management | 25,740 | 0 | 0 | 0 | For |
| Vanguard | 21,917 | 0 | 0 | 0 | For |
| Northern Trust | 19,441 | 0 | 0 | 0 | For |
| Huber Capital Management LLC | 18,320 | 0 | 0 | 0 | For |
| Dimensional | 18,196 | 0 | 0 | 0 | For |
| SEGALL BRYANT & HAMILL, LLC | 16,021 | 0 | 0 | 0 | For |
| Newton Investment Management North America, LLC | 15,700 | 0 | 0 | 0 | For |
| LPL Financial LLC | 11,638 | 0 | 0 | 0 | For |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 9,971 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 9,300 | 0 | 0 | 0 | For |
| RBC Capital Markets, LLC | 8,722 | 0 | 0 | 0 | For |
| American Century | 7,263 | 0 | 0 | 0 | For |
| DE Shaw | 7,227 | 0 | 0 | 0 | For |
| MERCER GLOBAL ADVISORS INC /ADV | 7,156 | 0 | 0 | 0 | For |
| ENVESTNET ASSET MANAGEMENT INC | 5,873 | 0 | 0 | 0 | For |
| Nuveen | 5,669 | 0 | 0 | 0 | For |
| AllianceBernstein | 5,300 | 0 | 0 | 0 | For |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 5,000 | 0 | 0 | 0 | For |
Institutional-manager reports, all 88 managers: 774,689 for, 2,380 against, 35 not voted. Showing the 25 largest; every one is in the interactive database (link above).
98% Majority: yes · of votes cast
Description as filed by funds: To approve, by advisory vote, the Company's executive compensation program.
Utah Medical Products, Inc.’s own tally for this item (“Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion:”): 2,354,919 for, 38,451 against, per its Form 8-K filed May 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Datum One Series Trust | 169,724 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 14,602 | 0 | 0 | 0 | For |
| Charles Schwab | 10,532 | 0 | 0 | 0 | For |
| Series Portfolios Trust | 3,100 | 0 | 0 | 0 | For |
| Global X | 1,377 | 0 | 0 | 0 | For |
| SEI | 700 | 0 | 0 | 0 | For |
| NEW COVENANT FUNDS | 515 | 0 | 0 | 0 | For |
| Nationwide | 422 | 0 | 0 | 0 | For |
| Vanguard | 370 | 0 | 0 | 0 | For |
| JPMorgan | 256 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 256 | 0 | 0 | 0 | For |
Fund voting reports, all 11 managers: 201,854 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BRANDES INVESTMENT PARTNERS, LP | 215,968 | 0 | 0 | 0 | For |
| RICE HALL JAMES & ASSOCIATES, LLC | 61,457 | 0 | 0 | 0 | For |
| Charles Schwab | 11,254 | 0 | 0 | 0 | For |
| LSV ASSET MANAGEMENT | 7,700 | 1,229 | 0 | 0 | Mixed |
| Penobscot Investment Management Company, Inc. | 4,000 | 0 | 0 | 0 | For |
| Metis Global Partners, LLC | 3,447 | 0 | 0 | 0 | For |
| Acuitas Investments, LLC | 3,100 | 0 | 0 | 0 | For |
| MACKENZIE FINANCIAL CORP | 2,040 | 0 | 0 | 0 | For |
| NEW YORK STATE COMMON RETIREMENT FUND | 1,429 | 0 | 0 | 0 | For |
| JPMorgan | 1,228 | 0 | 0 | 0 | For |
| WASHINGTON STATE INVESTMENT BOARD | 1,144 | 0 | 0 | 0 | For |
| SEI | 1,133 | 0 | 0 | 0 | For |
| Universal-Investment-Gesellschaft mbH | 1,000 | 0 | 0 | 0 | For |
| Neuberger Berman | 732 | 0 | 0 | 0 | For |
| Summit Trail Advisors, LLC | 654 | 0 | 0 | 0 | For |
| BANK OF AMERICA NA | 466 | 0 | 0 | 0 | For |
| XPONANCE LLC | 21 | 419 | 0 | 0 | Against |
| Russell Investments | 300 | 0 | 0 | 0 | For |
| Prudential/PGIM | 260 | 0 | 0 | 0 | For |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 0 | 251 | 0 | 0 | Against |
| NISA INVESTMENT ADVISORS, LLC | 0 | 198 | 0 | 0 | Against |
| Ethic Inc. | 0 | 155 | 0 | 0 | Against |
| Donor Advised Charitable Giving, Inc. | 0 | 0 | 0 | 0 | Not Voted |
| STATE OF MICHIGAN RETIREMENT SYSTEM | 100 | 0 | 0 | 0 | For |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 55 | 0 | 0 | 0 | For |
Institutional-manager reports, all 29 managers: 317,612 for, 2,252 against, 135 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
Description as filed by funds: To ratify the selection of Haynie & Company as the Company's independent public accounting firm for the year ending December 31, 2026; and
Utah Medical Products, Inc.’s own tally for this item (“Ratified the selection of Haynie & Co. as the Company’s independent public accounting firm for the year ended December 31, 2026:”): 2,753,278 for, 16,273 against, per its Form 8-K filed May 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 52 asset managers below reported 748,965 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Datum One Series Trust | 169,724 | 0 | 0 | 0 | For |
| Vanguard | 153,941 | 0 | 0 | 0 | For |
| Fidelity | 107,545 | 0 | 0 | 0 | For |
| BlackRock | 89,024 | 0 | 0 | 0 | For |
| Dimensional | 48,242 | 0 | 0 | 0 | For |
| HOTCHKIS & WILEY FUNDS /DE/ | 21,800 | 0 | 0 | 0 | For |
| ADVISORS SERIES TRUST | 17,595 | 0 | 0 | 0 | For |
| Principal | 16,287 | 0 | 0 | 0 | For |
| CLEARWATER INVESTMENT TRUST | 14,602 | 0 | 0 | 0 | For |
| Charles Schwab | 10,532 | 0 | 0 | 0 | For |
| WisdomTree | 9,439 | 0 | 0 | 0 | For |
| Prudential/PGIM | 8,497 | 0 | 0 | 0 | For |
| Equitable | 8,365 | 0 | 0 | 0 | For |
| American Century | 7,263 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 7,100 | 0 | 0 | 0 | For |
| Empower | 6,500 | 0 | 0 | 0 | For |
| TIAA | 5,619 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 5,035 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 5,000 | 0 | 0 | 0 | For |
| EA Series Trust | 3,278 | 0 | 0 | 0 | For |
| Northern Trust | 3,227 | 0 | 0 | 0 | For |
| Invesco | 3,122 | 0 | 0 | 0 | For |
| Series Portfolios Trust | 3,100 | 0 | 0 | 0 | For |
| Goldman Sachs | 2,715 | 0 | 0 | 0 | For |
| TETON WESTWOOD FUNDS | 2,000 | 0 | 0 | 0 | For |
Showing the 25 largest of 52 asset managers. All 52 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 3,185,025 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Datum One Series Trust | 5.33% |
| 2 | Vanguard | 4.83% |
| 3 | Fidelity | 3.38% |
| 4 | BlackRock | 2.80% |
| 5 | Dimensional | 1.51% |
| 6 | HOTCHKIS & WILEY FUNDS /DE/ | 0.68% |
| 7 | ADVISORS SERIES TRUST | 0.55% |
| 8 | Principal | 0.51% |
| 9 | CLEARWATER INVESTMENT TRUST | 0.46% |
| 10 | Charles Schwab | 0.33% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Renaissance | 4.39% |
| 2 | GEODE CAPITAL MANAGEMENT, LLC | 3.69% |
| 3 | HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 2.62% |
| 4 | BlackRock | 2.11% |
| 5 | State Street | 1.68% |
| 6 | T. Rowe Price | 1.05% |
| 7 | PARAMETRIC PORTFOLIO ASSOCIATES LLC | 0.93% |
| 8 | Cardinal Capital Management | 0.81% |
| 9 | Vanguard | 0.69% |
| 10 | Northern Trust | 0.61% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| BRANDES INVESTMENT PARTNERS, LP | 475,158 | 14.92% | Schedule 13G, filed August 14, 2026 |
| Dimensional Fund Advisors | 197,908 | 6.21% | Form 13F, quarter ended March 31, 2026 |
| BlackRock | 187,649 | 5.89% | Form 13F, quarter ended March 31, 2026 |
| Renaissance Technologies | 184,114 | 5.78% | Form 13F, quarter ended March 31, 2026 |
| Vanguard Group | 175,971 | 5.52% | Form 13F, quarter ended March 31, 2026 |
| Geode Capital | 120,097 | 3.77% | Form 13F, quarter ended March 31, 2026 |
| State Street | 64,402 | 2.02% | Form 13F, quarter ended March 31, 2026 |
| Morgan Stanley | 43,705 | 1.37% | Form 13F, quarter ended March 31, 2026 |
| BNY Mellon | 32,082 | 1.01% | Form 13F, quarter ended March 31, 2026 |
| Northern Trust | 30,292 | 0.95% | Form 13F, quarter ended March 31, 2026 |
Percentages above are of 3,185,025 shares outstanding, as reported by Utah Medical Products, Inc. on its Form 10-K dated March 26, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At Utah Medical Products, Inc.'s shareholder meeting held May 1, 2026, in the 2025-2026 proxy season, 155 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 671 separate fund positions. Their filings are grouped here into 5 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To hold an advisory vote on the Company's executive compensation program. — FOR was 98% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Utah Medical Products, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 4, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Utah Medical Products, Inc.’s 10-K dated March 26, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
Utah Medical Products, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “Utah Medical Products (UTMD) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/utah-medical-products-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.